Paul Goddard, Director at ONYX PHARMACEUTICALS INC (ONXX), sold 5,000 shares at $85.00 ($416K) on 2013-01-09, disclosed to the SEC on 2013-01-11.
Scheduled sale ($416k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.75 | 4,000 | $331K | 79.6% |
| 2 | $85.00 | 1,000 | $85K | 20.4% |
| Total | $83.20 avg | 5,000 | $416K | 100% |
| Filing → |
| ONXX | SELL | 2013-05-03 | $465K | — | Filing → |
| ONXX | SELL | 2013-04-11 | $190K | — | Filing → |
| ONXX | SELL | 2013-03-11 | $85K | — | Filing → |